2025年性行為感染傳染病（STD）檢測全球市場報告

預計未來幾年性行為感染傳染病 (STD) 檢測市場規模將強勁成長，到 2029 年將達到 120.8 億美元，年複合成長率（CAGR）為 8.3%。這一成長由一系列關鍵促進因素推動，包括全球性傳染病盛行率上升、性健康意識增強、無症狀感染率高、性活躍青少年和年輕人數量增加以及危險性行為激增。預測的主要趨勢包括快速和就地檢驗的興起、家用性傳染病檢測套組的出現、分子診斷技術的進步、診斷實驗室自動化和人工智慧整合度的提高以及新型檢測套組準確性和可靠性的提高。

預計愛滋病毒感染率的上升將在未來幾年推動性行為感染傳染病 (STD) 檢測市場的成長。愛滋病毒攻擊並破壞重要的白血球，從而削弱免疫系統，使人們更容易受到感染疾病和疾病的侵害。愛滋病毒病例的增加導致更多的人採取無保護性行為等危險行為，而接受檢測的人越來越少，尤其是年輕人。愛滋病毒病例的增加提高了公眾和醫療相關人員的認知，導致更多的人接受全面檢測以儘早發現感染並防止進一步傳播。例如，根據聯合國愛滋病毒聯合規劃署 (UNAIDS) 2024 年 7 月的數據，2023 年新增愛滋病毒感染者約有 130 萬，幾乎是 2025 年低於 37 萬的目標的三倍。因此，預計愛滋病毒感染率的上升將推動對性傳染病檢測的需求。

為了提高可及性和準確性，性行為感染傳染病 (STD) 檢測市場的主要參與者正專注於開發梅毒檢測套組等先進解決方案。這些套件使用血液和其他體液來檢測梅毒的病原體梅毒螺旋體，以便能夠及時診斷和治療。例如，2023 年 8 月，美國醫療設備公司 iHealth Labs Inc. 推出了 HIV 和梅毒檢測的 CheckMeSafe 家用採集試劑套件。這款經 FDA 批准的套件允許 18 歲及以上的個人在家中採集血液樣本進行 HIV（i、ii、P24 抗原）和梅毒檢測。使用者可以使用預付的隔夜標籤將樣本送到實驗室，並在短短兩天內收到保密、可靠的結果。套件對 HIV 的敏感度達到 99.9%，對梅毒的敏感度達到 99.5%，具有很高的準確性。所有樣本均在 CLIA 認證和 CAP 認可的實驗室進行測試，定期測試確保符合嚴格的聯邦和州品質標準。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球性行為感染傳染病 (STD) 檢測：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球性行為感染傳染病（STD）檢測市場：成長率分析
• 全球性行為感染傳染病 (STD) 檢測市場表現：規模與成長，2019-2024 年
• 全球性行為感染傳染病 (STD) 檢測市場預測：規模與成長，2024-2029 年，2034 年預測
• 全球性行為感染傳染病（STD）檢測：總目標市場（TAM）

第6章市場區隔

• 全球性行為感染傳染病 (STD) 檢測市場（按產品、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 設備和服務
• 耗材
• 軟體
• 全球性行為感染傳染病 (STD) 檢測市場（按技術、績效和預測），2019-2024 年、2024-2029 年、2034 年
• 免疫檢測
• 分子診斷
• 全球性行為感染傳染病 (STD) 檢測市場（按樣本類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
• 血液樣本
• 尿液樣本
• 棉花棒
• 精液樣本
• 其他樣本類型
• 全球性行為感染傳染病 (STD) 檢測市場（按疾病類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
• 披衣菌感染
• 淋病
• 梅毒
• HIV或愛滋病
• 單純皰疹病毒（HSV）
• 全球性行為感染傳染病 (STD) 檢測市場（按最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 個人
• 醫療保健提供者
• 健康保險公司
• 政府衛生機構
• 非政府組織和社區健康組織
• 全球性行為感染傳染病 (STD) 檢測市場、設備和服務、按類型細分：實際和預測，2019-2024 年、2024-2029 年、2034 年
• 診斷設備
• 測試服務
• 全球性行為感染傳染病 (STD) 檢測市場、耗材、按類型細分：實際和預測，2019-2024 年、2024-2029 年、2034 年
• 試劑和套件
• 檢體裝置
• 玻片、試管和其他實驗室用品
• 全球性行為感染傳染病 (STD) 檢測市場、軟體、按類型細分：實際和預測，2019-2024 年、2024-2029 年、2034 年
• 實驗室資訊管理系統（LIMS）
• 電子健康記錄 (EHR) 整合工具
• 數據分析和報告工具
• 病人管理軟體

第7章 區域和國家分析

• 全球性行為感染傳染病 (STD) 檢測市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球性行為感染傳染病 (STD) 檢測市場：按國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 性行為感染傳染病（STD）檢測市場：競爭格局
• 性行為感染傳染病（STD）檢測市場：公司簡介
  • F Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson And Co. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Hologic Inc.
• QuidelOrtho Corp.
• Bio-Rad Laboratories Inc.
• Cepheid
• OraSure Technologies Inc.
• Meridian Bioscience Inc.
• Sekisui Diagnostics Ltd.
• Trinity Biotech Plc
• Chembio Diagnostics Inc.
• Operon SA
• Jal Medical Pte. Ltd.
• Anatolia Geneworks
• CLIAwaived Inc.
• Avecon Healthcare Pvt. Ltd.
• AEHEALTH LIMITED

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年性行為感染傳染病（STD）檢測市場：提供新機會的國家
• 2029年性行為感染傳染病（STD）檢測市場：細分市場帶來新機會
• 2029年性行為感染傳染病（STD）檢測市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

Sexually transmitted disease (STD) testing refers to the medical procedure used to detect infections primarily transmitted through sexual contact. It is essential for early diagnosis, which helps prevent complications and controls the spread of infections through timely treatment and counseling. Regular screening is often advised for sexually active individuals since many infections may not present immediate symptoms but can still be contagious.

The main components of sexually transmitted disease (STD) testing include instruments and services, consumables, and software. Instruments and services comprise the diagnostic devices and support activities utilized in clinical environments for conducting medical tests. These employ both immunoassay and molecular diagnostic technologies and can analyze blood, urine, swabs, semen, and other sample types. This testing is applied for various diseases such as chlamydia, gonorrhea, syphilis, HIV/AIDS, and herpes simplex virus (HSV), serving a range of end users including individuals, healthcare providers, health insurers, government health agencies, NGOs, and community health organizations.

The sexually transmitted diseases (STD) testing market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted diseases (STD) testing market statistics, including sexually transmitted diseases (STD) testing industry global market size, regional shares, competitors with a sexually transmitted diseases (STD) testing market share, detailed sexually transmitted diseases (STD) testing market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted diseases (STD) testing industry. This sexually transmitted diseases (STD) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sexually transmitted diseases (STD) testing market size has grown strongly in recent years. It will grow from $8.08 billion in 2024 to $8.78 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. Growth during the past years has been driven by increasing urbanization and population density, a growing aging population maintaining active sexual lifestyles, government efforts to promote STD screening, the integration of STD testing into routine health examinations, and greater funding for public health initiatives.

The sexually transmitted diseases (STD) testing market size is expected to see strong growth in the next few years. It will grow to $12.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. This anticipated expansion can be credited to the rising global incidence of STDs, enhanced awareness of sexual health issues, the high rate of infections without symptoms, the increasing number of sexually active adolescents and young adults, and a surge in risky sexual behaviors. Key trends forecasted include the rise of rapid and point-of-care testing, the emergence of home-based STD testing kits, progress in molecular diagnostic methods, greater automation and AI integration in diagnostic labs, and improved accuracy and reliability of new testing kits.

The increasing prevalence of HIV is expected to drive the growth of the sexually transmitted diseases (STD) testing market in the upcoming years. HIV attacks and destroys vital white blood cells, weakening the immune system and making the body more susceptible to infections and diseases. The rise in HIV cases is linked to a decline in awareness and prevention efforts, leading to more individuals engaging in risky behaviors such as unprotected sex and fewer people, especially youth, getting tested. This increase in HIV cases has raised public and healthcare awareness, encouraging more people to seek comprehensive testing to detect infections early and prevent further spread. For example, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) in July 2024, approximately 1.3 million people were newly infected with HIV in 2023, nearly three times higher than the 2025 target of fewer than 370,000 cases. Therefore, the growing prevalence of HIV is expected to enhance the demand for STD testing.

Key players in the sexually transmitted diseases (STD) testing market are focusing on the development of advanced solutions, such as syphilis testing kits, to improve accessibility and accuracy. These kits detect the Treponema pallidum bacteria, which causes syphilis, using blood or other bodily fluids, enabling timely diagnosis and treatment. For instance, in August 2023, iHealth Labs Inc., a US medical device company, launched the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit allows individuals aged 18 and older to collect blood samples at home for HIV (I, II, P24 antigen) and syphilis testing. Users can send their samples to the lab with a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit offers high accuracy, with sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are tested in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with stringent federal and state quality standards through regular inspections.

In December 2023, imaware, a US-based company providing at-home health testing kits, acquired binx health's at-home consumer testing division. This acquisition will help imaware strengthen its position in the growing home-health testing market and expand its enterprise client base. Meanwhile, binx health will continue to develop and grow its point-of-care molecular diagnostics division, which was not part of the acquisition. Binx health is a US-based provider of sexually transmitted disease (STD) testing solutions.

Major players in the sexually transmitted diseases (std) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson And Co., Hologic Inc., QuidelOrtho Corp., Bio-Rad Laboratories Inc., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Sekisui Diagnostics Ltd., Trinity Biotech Plc, Chembio Diagnostics Inc., Operon SA, Jal Medical Pte. Ltd., Anatolia Geneworks, CLIAwaived Inc., Avecon Healthcare Pvt. Ltd., and AEHEALTH LIMITED.

North America was the largest region in the sexually transmitted diseases (STD) testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted diseases (STD) testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sexually transmitted diseases (STD) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sexually transmitted diseases (STD) testing market consists of revenues earned by entities by providing services such as confidential testing, walk-in clinic testing, online test ordering, telehealth consultations, and partner notification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted diseases (STD) testing market also includes sales of at-home test kits, multi-infection panel kits, blood collection devices, biohazard specimen bags, and portable sample storage containers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sexually Transmitted Diseases (STD) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sexually transmitted diseases (std) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sexually transmitted diseases (std) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sexually transmitted diseases (std) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Instruments And Services; Consumables; Software
• 2) By Technology: Immunoassay; Molecular Diagnostics
• 3) By Sample Type: Blood Samples; Urine Samples; Swabs; Semen Samples; Other Sample Types
• 4) By Disease Type: Chlamydia; Gonorrhea; Syphilis; HIV Or AIDS; Herpes Simplex Virus (HSV)
• 5) By End User: Individuals; Healthcare Providers; Health Insurance Providers; Govement Health Agencies; NGOs And Community Health Organizations
• Subsegments:
• 1) By Instruments And Services: Diagnostic Instruments; Testing Services
• 2) By Consumables: Reagents And Kits; Specimen Collection Devices; Slides, Tubes, And Other Lab Supplies
• 3) By Software: Laboratory Information Management Systems (LIMS); Electronic Health Records (EHR) Integration Tools; Data Analysis And Reporting Tools; Patient Management Software
• Companies Mentioned: F Hoffmann La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Siemens Healthineers AG; Becton Dickinson And Co.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sexually Transmitted Diseases (STD) Testing Market Characteristics

3. Sexually Transmitted Diseases (STD) Testing Market Trends And Strategies

4. Sexually Transmitted Diseases (STD) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sexually Transmitted Diseases (STD) Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sexually Transmitted Diseases (STD) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sexually Transmitted Diseases (STD) Testing Market Growth Rate Analysis
• 5.4. Global Sexually Transmitted Diseases (STD) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sexually Transmitted Diseases (STD) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sexually Transmitted Diseases (STD) Testing Total Addressable Market (TAM)

6. Sexually Transmitted Diseases (STD) Testing Market Segmentation

• 6.1. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments And Services
• Consumables
• Software
• 6.2. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay
• Molecular Diagnostics
• 6.3. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Samples
• Urine Samples
• Swabs
• Semen Samples
• Other Sample Types
• 6.4. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chlamydia
• Gonorrhea
• Syphilis
• HIV Or AIDS
• Herpes Simplex Virus (HSV)
• 6.5. Global Sexually Transmitted Diseases (STD) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Individuals
• Healthcare Providers
• Health Insurance Providers
• Govement Health Agencies
• NGOs And Community Health Organizations
• 6.6. Global Sexually Transmitted Diseases (STD) Testing Market, Sub-Segmentation Of Instruments And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Instruments
• Testing Services
• 6.7. Global Sexually Transmitted Diseases (STD) Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Specimen Collection Devices
• Slides, Tubes, and Other Lab Supplies
• 6.8. Global Sexually Transmitted Diseases (STD) Testing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Information Management Systems (LIMS)
• Electronic Health Records (EHR) Integration Tools
• Data Analysis And Reporting Tools
• Patient Management Software

7. Sexually Transmitted Diseases (STD) Testing Market Regional And Country Analysis

• 7.1. Global Sexually Transmitted Diseases (STD) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sexually Transmitted Diseases (STD) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market

• 8.1. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sexually Transmitted Diseases (STD) Testing Market

• 9.1. China Sexually Transmitted Diseases (STD) Testing Market Overview
• 9.2. China Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sexually Transmitted Diseases (STD) Testing Market

• 10.1. India Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sexually Transmitted Diseases (STD) Testing Market

• 11.1. Japan Sexually Transmitted Diseases (STD) Testing Market Overview
• 11.2. Japan Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sexually Transmitted Diseases (STD) Testing Market

• 12.1. Australia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sexually Transmitted Diseases (STD) Testing Market

• 13.1. Indonesia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sexually Transmitted Diseases (STD) Testing Market

• 14.1. South Korea Sexually Transmitted Diseases (STD) Testing Market Overview
• 14.2. South Korea Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sexually Transmitted Diseases (STD) Testing Market

• 15.1. Western Europe Sexually Transmitted Diseases (STD) Testing Market Overview
• 15.2. Western Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sexually Transmitted Diseases (STD) Testing Market

• 16.1. UK Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sexually Transmitted Diseases (STD) Testing Market

• 17.1. Germany Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sexually Transmitted Diseases (STD) Testing Market

• 18.1. France Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sexually Transmitted Diseases (STD) Testing Market

• 19.1. Italy Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sexually Transmitted Diseases (STD) Testing Market

• 20.1. Spain Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market

• 21.1. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market Overview
• 21.2. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sexually Transmitted Diseases (STD) Testing Market

• 22.1. Russia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sexually Transmitted Diseases (STD) Testing Market

• 23.1. North America Sexually Transmitted Diseases (STD) Testing Market Overview
• 23.2. North America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sexually Transmitted Diseases (STD) Testing Market

• 24.1. USA Sexually Transmitted Diseases (STD) Testing Market Overview
• 24.2. USA Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sexually Transmitted Diseases (STD) Testing Market

• 25.1. Canada Sexually Transmitted Diseases (STD) Testing Market Overview
• 25.2. Canada Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sexually Transmitted Diseases (STD) Testing Market

• 26.1. South America Sexually Transmitted Diseases (STD) Testing Market Overview
• 26.2. South America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sexually Transmitted Diseases (STD) Testing Market

• 27.1. Brazil Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sexually Transmitted Diseases (STD) Testing Market

• 28.1. Middle East Sexually Transmitted Diseases (STD) Testing Market Overview
• 28.2. Middle East Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sexually Transmitted Diseases (STD) Testing Market

• 29.1. Africa Sexually Transmitted Diseases (STD) Testing Market Overview
• 29.2. Africa Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sexually Transmitted Diseases (STD) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sexually Transmitted Diseases (STD) Testing Market Competitive Landscape And Company Profiles

• 30.1. Sexually Transmitted Diseases (STD) Testing Market Competitive Landscape
• 30.2. Sexually Transmitted Diseases (STD) Testing Market Company Profiles
  • 30.2.1. F Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson And Co. Overview, Products and Services, Strategy and Financial Analysis

31. Sexually Transmitted Diseases (STD) Testing Market Other Major And Innovative Companies

• 31.1. Hologic Inc.
• 31.2. QuidelOrtho Corp.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Cepheid
• 31.5. OraSure Technologies Inc.
• 31.6. Meridian Bioscience Inc.
• 31.7. Sekisui Diagnostics Ltd.
• 31.8. Trinity Biotech Plc
• 31.9. Chembio Diagnostics Inc.
• 31.10. Operon SA
• 31.11. Jal Medical Pte. Ltd.
• 31.12. Anatolia Geneworks
• 31.13. CLIAwaived Inc.
• 31.14. Avecon Healthcare Pvt. Ltd.
• 31.15. AEHEALTH LIMITED

32. Global Sexually Transmitted Diseases (STD) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sexually Transmitted Diseases (STD) Testing Market

34. Recent Developments In The Sexually Transmitted Diseases (STD) Testing Market

35. Sexually Transmitted Diseases (STD) Testing Market High Potential Countries, Segments and Strategies

• 35.1 Sexually Transmitted Diseases (STD) Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sexually Transmitted Diseases (STD) Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sexually Transmitted Diseases (STD) Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer